Skip to main content
. 2014 Apr;52(4):1246–1249. doi: 10.1128/JCM.03119-13

TABLE 2.

Specificity of assay Ba

Bacterial species Sourceb Isolate origin Resultc
Mycobacterium abscessus NRZ Humand
Mycobacterium africanum NRZ Humand
Mycobacterium avium NRZ Humand
Mycobacterium bovis NRZ Cattled
Mycobacterium chelonae NRZ Humand
Mycobacterium fortuitum NRZ Humane
Mycobacterium gordonae NRZ Humane
Mycobacterium gordonae DITM Humane
Mycobacterium kansasii NRZ Humand
Mycobacterium leprae DITM Humand
Mycobacterium malmoense NRZ Humane
Mycobacterium marinum NRZ Humand +
Mycobacterium microti NRZ Moused
Mycobacterium scrofulaceum NRZ Humand
Mycobacterium smegmatis NRZ Humand
Mycobacterium szulgai NRZ Humand
Mycobacterium tuberculosis NRZ Humand
Mycobacterium ulcerans DITM Humand +
Mycobacterium xenopi NRZ Humane
Escherichia coli MVP Humane
Propionibacterium acnes MVP Humand
Staphylococcus aureus MVP Humane
Staphylococcus epidermidis MVP Humane
Streptococcus pyogenes MVP Humand
a

Shown are (myco)bacterial species commonly contaminating human skin and the results of the specificity testing of sequencing assay B.

b

DNA extracts that were not available at the Department of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-University, Munich, Germany (DITM) were provided by the National Reference Center for Mycobacteria, Borstel, Germany (NRZ), and the Max von Pettenkofer-Institut, Ludwig-Maximilians-University, Munich, Germany (MVP).

c

Results of DNA extracts subjected to assay B: +, positive PCR result; −, negative PCR result.

d

The primary patient isolates were considered pathogenic bacteria.

e

The primary patient isolates were considered commensals/contaminants of clinical samples.